Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Aph(3′)-IIc, an Aminoglycoside Resistance Determinant from Stenotrophomonas maltophilia

Aki Okazaki, Matthew B. Avison
Aki Okazaki
Bristol Centre for Antimicrobial Research and Evaluation, Department of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew B. Avison
Bristol Centre for Antimicrobial Research and Evaluation, Department of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: matthewb.Avison@bris.ac.uk
DOI: 10.1128/AAC.00795-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1128/AAC.00795-06
PubMed 
17088477

Published By 
American Society for Microbiology Journals
History 
  • Received July 1, 2006
  • Returned for modification August 12, 2006
  • Accepted October 23, 2006
  • Published online December 20, 2006.

Copyright & Usage 
Copyright © 2007 American Society for Microbiology

Article Versions

  • Accepted Manuscript version (November 06, 2006).
  • You are viewing the most recent version of this article.

Author Information

  1. Aki Okazaki and
  2. Matthew B. Avison*
  1. Bristol Centre for Antimicrobial Research and Evaluation, Department of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
  • ↵* Corresponding author. Mailing address: Department of Cellular and Molecular Medicine, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1TD, United Kingdom. Phone: 44 (0)11792857528. Fax: 44 (0)1179287896. E-mail: matthewb.Avison{at}bris.ac.uk .

Article usage

Article usage: November 2006 to March 2021

Rendering graph...
AbstractFullPdf
Nov 200610029
Dec 2006321332
Jan 2007292719
Feb 20072867
Mar 2007111219
Apr 200715415
May 200721317
Jun 20073617
Jul 200710613
Aug 200731619
Sep 200741912
Oct 200731713
Nov 200791616
Dec 20072118
Jan 200831318
Feb 20084147
Mar 200841720
Apr 200841317
May 20080912
Jun 20084719
Jul 200891313
Aug 200872210
Sep 200822119
Oct 20081168
Nov 200831617
Dec 2008286
Jan 200961813
Feb 200981911
Mar 20093911
Apr 200922014
May 200971010
Jun 200941516
Jul 20097179
Aug 200971711
Sep 2009569
Oct 200971514
Nov 200971311
Dec 20090711
Jan 201031312
Feb 201051316
Mar 201002120
Apr 201012114
May 201024330
Jun 201093422
Jul 201052015
Aug 201082716
Sep 201041410
Oct 2010112912
Nov 201093018
Dec 2010133411
Jan 20119206
Feb 201181613
Mar 20119169
Apr 201172213
May 201182027
Jun 20116164
Jul 20119188
Aug 201171116
Sep 201142714
Oct 201162219
Nov 20117239
Dec 2011131211
Jan 2012121612
Feb 201292312
Mar 2012102211
Apr 20123129
May 201251212
Jun 2012794
Jul 201241611
Aug 2012895
Sep 20121088
Oct 20124158
Nov 201261512
Dec 20129156
Jan 20133142
Feb 20138176
Mar 20134236
Apr 2013102614
May 201362613
Jun 20137274
Jul 20138183
Aug 20133248
Sep 20137168
Oct 20136213
Nov 20136186
Dec 20134136
Jan 2014693
Feb 2014787
Mar 20141154
Apr 201416117
May 2014101311
Jun 2014686
Jul 201411176
Aug 2014353
Sep 2014162
Oct 20141269
Nov 201451212
Dec 201421106
Jan 201512812
Feb 20154104
Mar 2015101110
Apr 20154104
May 201511719
Jun 20151283
Jul 2015563
Aug 20151466
Sep 20151178
Oct 2015598
Nov 2015383
Dec 2015904
Jan 20163627
Feb 2016864
Mar 20162769
Apr 201614128
May 2016879
Jun 20161133
Jul 20161026
Aug 2016726
Sep 2016735
Oct 2016532
Nov 20162045
Dec 2016611
Jan 20171154
Feb 2017840
Mar 2017723
Apr 2017601
May 20171215
Jun 2017661
Jul 2017112
Aug 2017200
Sep 2017222
Oct 2017375
Nov 2017461
Dec 2017923
Jan 2018434
Feb 2018380
Mar 2018555
Apr 2018320
May 20182366
Jun 20181241
Jul 2018773
Aug 2018675
Sep 20180105
Oct 20181136
Nov 20180712
Dec 20180125
Jan 2019223
Feb 2019568
Mar 2019153
Apr 2019066
May 20192129
Jun 2019151
Jul 2019479
Aug 201941215
Sep 20193105
Oct 20192124
Nov 20196410
Dec 20197189
Jan 20202910
Feb 202013921
Mar 2020886
Apr 202052313
May 202061613
Jun 2020236
Jul 20206124
Aug 2020165
Sep 20201157
Oct 20203911
Nov 2020388
Dec 20202122
Jan 2021388
Feb 20213910
Mar 2021010
PreviousNext
Back to top
Download PDF
Citation Tools
Aph(3′)-IIc, an Aminoglycoside Resistance Determinant from Stenotrophomonas maltophilia
Aki Okazaki, Matthew B. Avison
Antimicrobial Agents and Chemotherapy Dec 2006, 51 (1) 359-360; DOI: 10.1128/AAC.00795-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Aph(3′)-IIc, an Aminoglycoside Resistance Determinant from Stenotrophomonas maltophilia
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Aph(3′)-IIc, an Aminoglycoside Resistance Determinant from Stenotrophomonas maltophilia
Aki Okazaki, Matthew B. Avison
Antimicrobial Agents and Chemotherapy Dec 2006, 51 (1) 359-360; DOI: 10.1128/AAC.00795-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

aminoglycosides
Drug Resistance, Multiple, Bacterial
Kanamycin Kinase
Stenotrophomonas maltophilia

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596